The increasing prevalence of eye conditions, such as cataracts, macular degeneration, and diabetic retinopathy, is a significant driver of the global ophthalmology market. As the global population ages, the incidence of these conditions is rise. Cataracts, which lead to blurred vision and blindness, demand an expanding market for surgeries and corrective treatments. Similarly, macular degeneration and diabetic retinopathy are contributing to the need for advanced diagnostic tools and specialized therapies. The growing number of affected individuals ensures sustained demand for eye care services, including surgeries, medications, and innovative diagnostic technologies. This surge in eye diseases directly drives market expansion, as healthcare providers and manufacturers strive to meet the growing need for effective treatments and solutions.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-ophthalmology-market
Data Bridge Market Research analyzes that the Global Ophthalmology Market is expected to reach USD 130.74 billion by 2032 from USD 78.28 billion in 2024, growing at a CAGR of 6.7% in the forecast period of 2025 to 2032.
Key Findings of the Study
Increasing Prevalence of Eye Diseases
The increasing prevalence of eye conditions, such as cataracts, macular degeneration, and diabetic retinopathy, is a significant driver of the global ophthalmology market. As the global population ages, the incidence of these conditions is rise. Cataracts, which lead to blurred vision and blindness, demand an expanding market for surgeries and corrective treatments. Similarly, macular degeneration and diabetic retinopathy are contributing to the need for advanced diagnostic tools and specialized therapies. The growing number of affected individuals ensures sustained demand for eye care services, including surgeries, medications, and innovative diagnostic technologies. This surge in eye diseases directly drives market expansion, as healthcare providers and manufacturers strive to meet the growing need for effective treatments and solutions.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2025 to 2032
|
|
Base Year
|
2024
|
|
Historic Year
|
2023 (Customizable 2013-2017)
|
|
Quantitative Units
|
Revenue in USD Billion
|
|
Segments Covered
|
Products (Device, Drugs, and Others), Diseases (Cataract, Refractive Disorders, Glaucoma, Age-Related Macular Degeneration, Inflammatory Diseases, and Others), Comprehensive Eye Examination (Refraction, Visual Acuity Test, Intraocular Pressure, Anterior Segment and Pupillary Examination, Visual Fields Test, Color Vision Test, and Others), End User (Clinics, Hospitals, Home Healthcare, and Others), Distribution Channel (Retail Sales, Direct Tender, and Others)
|
|
Countries Covered
|
U.S, Canada, Mexico, Germany, France, U.K., Italy, Spain, Switzerland, Russia, Belgium, Netherlands, Turkey, Rest of Europe, China, India, Japan, South Korea, Australia, Indonesia, Thailand, Malaysia, Philippines, Singapore, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa
|
|
Market Players Covered
|
Alcon (Switzerland), Bausch + Lomb (Canada), Carl Zeiss Meditec (Germany), Hoya Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.), Essilor International (France), Topcon Corporation (Japan), Glaukos Corporation (U.S.), Haag-Streit Group (Switzerland), Nidek Co., Ltd (U.S.), Staar Surgical (California), Ziemer Ophthalmic Systems Ag (Switzerland), Cooper Companies (U.S.), Lumenis Be Ltd. (Israel), Reichert Inc. (New York), Bayer Ag (Germany), Novartis Ag (Switzerland), Abbvie Inc.(U.S.), F. Hoffmann-La Roche Ltd.(Switzerland), Dompé (Italy), Santen Pharmaceutical Co. (Japan), Ltd among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The market is segmented on the basis of products, diseases, comprehensive eye examination, end user, and distribution channel.
On the basis of products, the market is segmented into device, drugs, and others.
In 2025, the device segment is expected to dominate the global ophthalmology market
In 2025, the device segment is expected to dominate the market with a market share of 54.27%, because increasing prevalence of eye diseases.
- On the basis of diseases, the market is segmented into cataract, refractive disorders, glaucoma, age-related macular degeneration, inflammatory diseases, and others
In 2025, the cataract segment is expected to dominate the global ophthalmology market
In 2025, the cataract segment is expected to dominate the market with a market share of 31.29%, due to focus on preventative eye care.
- On the basis of comprehensive eye examination, the market is segmented into refraction, visual acuity test, intraocular pressure, anterior segment and pupillary examination, visual fields test, color vision test, and others. In 2025, the refraction segment is expected to dominate the market with a market share of 31.66%
- On the basis of end user, the market is segmented into clinics, hospitals, home healthcare, and others. In 2025, the clinics segment is expected to dominate the market with a market share of 47.07%
- On the basis of distribution channel, the market is segmented into retail sales, direct tender, and others. In 2025, the retail sales segment is expected to dominate the market with a market share of 60.37%
Major Players
Data Bridge Market Research Analyses that Alcon (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Bausch + Lomb (Canada), Essilor International (France), Novartis Ag (Switzerland) as major market players in this market.
Market Developments
- In October 2024, At the AAO 2024 meeting, Alcon showcased its innovations, including the Voyager DSLT for glaucoma treatment, UNIFEYE and UNIPEXY handheld gas delivery systems, and pivotal data for AR-15512, a dry eye treatment. These advancements aimed to improve outcomes and surgical efficiency
- In September 2024, EssilorLuxottica and Meta have extended their partnership, entering a long-term agreement to develop multi-generational smart eyewear products. Building on the success of Ray-Ban Meta glasses, the companies aim to shape the future of wearable technology together
- In OCTOBER 2024, Bausch + Lomb presented new scientific data and educational events at the 2024 AAO meeting in Chicago. Highlights included studies on the enVista Envy IOL, TENEO Excimer Laser, VYZULTA, and presentations on Blink Nutritears, MIEBO, and Xiidra
- In April 2024, AbbVie has completed its acquisition of Cerevel Therapeutics, enhancing its neuroscience portfolio. The acquisition includes Cerevel’s promising clinical-stage assets like Emraclidine for schizophrenia and Tavapadon for Parkinson's disease, strengthening AbbVie’s position in neurology and psychiatry
- In September, 2023, Novartis completed the divestment of its 'front of eye' ophthalmology assets to Bausch + Lomb for up to USD 2.5 billion, including USD 1.75 billion in upfront cash and potential milestone payments. The deal included Xiidra, SAF312, AcuStream, and OJL332. Novartis advanced its strategy to focus on prioritized therapeutic areas for future growth
Regional Analysis
Geographically, the countries covered in the global ophthalmology market report are U.S, Canada, Mexico, Germany, France, U.K., Italy, Spain, Switzerland, Russia, Belgium, Netherlands, Turkey, rest of Europe, China, India, Japan, South Korea, Australia, Indonesia, Thailand, Malaysia, Philippines, Singapore, rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa.
As per Data Bridge Market Research analysis:
North America is the dominant country in the global ophthalmology market
North America is expected to dominate the market due to increasing prevalence of eye diseases.
Asia-Pacific is estimated to be the fastest-growing country in the global ophthalmology market
Asia-Pacific is expected to be the fastest growing country in market, as the innovations in ophthalmic surgical techniques.
For more detailed information about the global ophthalmology market report, click here – https://www.databridgemarketresearch.com/reports/global-ophthalmology-market
